skip to Global Navigation Bar skip to main content

homeHome > R&D > Major Research Achievements

 Major Research Achievements

  • Nabota
  • Olostar
  • Daewoong EGF
  • Luphere
  • Ursa
  • Albis
  • Moxicle


Olostar pic


As what can manage both high blood pressure and dyslipidemia, it is the world’s first combination of olmesartan medoxomil in ARB, which is an agent for high blood pressure, and rosuvastatin in statin for dyslipidemia.


It applies the technology of delayed time elution regulated bilayer tablet, which stops the interaction of the two drugs (Registered patents KR1451081)


Olostar tablets are to be administered to patients who have to take both drugs of olmesartan medoxomil and rosuvastatin).

  • • Olmesartan medoxomil: for treatment of essential high blood pressure
  • • Rosuvastatin: for reducing the risks of hypercholesterinemia and cardiovascular diseases and delaying the progress of atheriosclerosis

2014 대한민국 신약개발상 기술수출부분 ‘기술수출상’ 수상 (한국신약개발연구조합)

  • Olostar